Insider Trading Alert - CUZ, MMS And PRAA Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 24, 2014, 153 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $614.00 to $8,867,579,754,879.72.

Highlighted Stocks Traded by Insiders:

Cousins Properties (CUZ) - FREE Research Report

Charlesworth Tom G who is Director at Cousins Properties sold 4,604 shares at $11.48 on Feb. 24, 2014. Following this transaction, the Director owned 39,029 shares meaning that the stake was reduced by 10.55% with the 4,604-share transaction.

The shares most recently traded at $11.40, down $0.08, or 0.71% since the insider transaction. Historical insider transactions for Cousins Properties go as follows:

  • 4-Week # shares sold: 30,436
  • 12-Week # shares sold: 30,436
  • 24-Week # shares sold: 54,936

The average volume for Cousins Properties has been 1.3 million shares per day over the past 30 days. Cousins Properties has a market cap of $2.2 billion and is part of the financial sector and real estate industry. Shares are up 11.16% year-to-date as of the close of trading on Monday.

Cousins Properties Incorporated, a real estate investment trust (REIT), owns, develops, and manages real estate portfolio, as well as performs certain real estate-related services in the United States. The stock currently has a dividend yield of 2.62%. The company has a P/E ratio of 17.4. Currently there are 3 analysts that rate Cousins Properties a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CUZ - FREE

TheStreet Quant Ratings rates Cousins Properties as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, reasonable valuation levels, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cousins Properties Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Maximus (MMS) - FREE Research Report

Caswell Bruce who is President - Health Services at Maximus sold 7,000 shares at $47.17 on Feb. 24, 2014. Following this transaction, the President - Health Services owned 31,135 shares meaning that the stake was reduced by 18.36% with the 7,000-share transaction.

The shares most recently traded at $48.24, up $1.07, or 2.22% since the insider transaction. Historical insider transactions for Maximus go as follows:

  • 4-Week # shares sold: 157,985
  • 12-Week # shares sold: 170,970
  • 24-Week # shares sold: 213,486

The average volume for Maximus has been 413,900 shares per day over the past 30 days. Maximus has a market cap of $3.2 billion and is part of the services sector and diversified services industry. Shares are up 9.14% year-to-date as of the close of trading on Monday.

MAXIMUS, Inc. provides business process services to government health and human services agencies in the United States, Australia, Canada, the United Kingdom, and Saudi Arabia. The company operates in two segments, Health Services and Human Services. The stock currently has a dividend yield of 0.38%. The company has a P/E ratio of 25.5. Currently there are 5 analysts that rate Maximus a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MMS - FREE

TheStreet Quant Ratings rates Maximus as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Maximus Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Portfolio Recovery Associates (PRAA) - FREE Research Report

McCammon Peter Kent who is EVP-Strategy and Business Dev. at Portfolio Recovery Associates sold 15,000 shares at $57.07 on Feb. 24, 2014. Following this transaction, the EVP-Strategy and Business Dev. owned 28,696 shares meaning that the stake was reduced by 34.33% with the 15,000-share transaction.

Petit Michael J who is President -Bankruptcy Services at Portfolio Recovery Associates sold 15,000 shares at $58.31 on Feb. 24, 2014. Following this transaction, the President -Bankruptcy Services owned 78,553 shares meaning that the stake was reduced by 16.03% with the 15,000-share transaction.

The shares most recently traded at $56.27, down $2.04, or 3.63% since the insider transaction. Historical insider transactions for Portfolio Recovery Associates go as follows:

  • 4-Week # shares sold: 4,100
  • 12-Week # shares sold: 15,000
  • 24-Week # shares sold: 44,036

The average volume for Portfolio Recovery Associates has been 586,300 shares per day over the past 30 days. Portfolio Recovery Associates has a market cap of $2.8 billion and is part of the services sector and diversified services industry. Shares are up 7.06% year-to-date as of the close of trading on Monday.

Portfolio Recovery Associates, Inc., a financial and business service company, engages in the purchase, collection, and management of portfolios of defaulted consumer receivables in the United States and the United Kingdom. The company has a P/E ratio of 16.6. Currently there are 4 analysts that rate Portfolio Recovery Associates a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRAA - FREE

TheStreet Quant Ratings rates Portfolio Recovery Associates as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Portfolio Recovery Associates Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Video: The S&P 500 Is Failing to Make New Highs

Video: The S&P 500 Is Failing to Make New Highs

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

Video: Jim Cramer on Apple, Procter & Gamble, Nucor and Acacia Communications

Video: Jim Cramer on Apple, Procter & Gamble, Nucor and Acacia Communications